FDA Calendar

April 22-27, San Francisco

AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS 2006 ANNUAL MEETING

Includes presentation from NeoPharm Inc. on cintredekin besudotox's phase 1 study targeting tumors

April 26-30, Vienna, Austria

41st ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Includes presentation from Idenix Pharmaceuticals Inc. on 13 abstracts, including Valopicitabine, and other presentations on liver transplantation, cirrhosis, tumors and viral hepatitis

April 27-29, Denver

AMERICAN HEART ASSOCIATION'S 7th ANNUAL CONFERENCE ON ARTERIOSCLEROSIS

Includes presentation from PreMD Inc. on Prevu Point of Care Skin Sterol Test, a cardiovascular product

April 29-May 2, San Francisco

PEDIATRIC ACADEMIC SOCIETIES' 2006 ANNUAL MEETING

Includes presentation from Tercica Inc. on methods for measuring anti-IGF-1 antibodies and growth studies in children

April 30-May 4, Fort Lauderdale, Fla.

2006 ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY

Includes presentation from ISTA Pharmaceuticals Inc. on Xibrom, an anti-inflammatory solution, and Vitrase, a spreading agent for hypodermoclysis

May 1-4, Carlsbad, Calif.

TIDES - OLIGONUCLEOTIDE AND PEPTIDE TECHNOLOGY AND PRODUCT DEVELOPMENT CONFERENCE 2006

Includes presentation from Helix BioMedix Inc. on hexapeptides for bacterial and fungal infections

May 3-4, Rockville, Md.

ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE MEETING (FDA)

Committee to review update from Clinical Pharmacology Subcommittee, discuss and provide comments on establishing drug release or dissolution specifications, receive update on activities of Parametric Tolerance Interval Test Workgroup, discuss criteria for establishing a working group for review and assessment of Office of Pharmaceutical Science research programs

May 3-6, San Antonio

AMERICAN PAIN SOCIETY'S 25th ANNUAL SCIENTIFIC MEETING

Includes presentation from DOV Pharmaceutical Inc. on Bicifadine as analgesic in animal models of neuropathic pain and data from phase 3 trial results

May 5, Rockville, Md.

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEETING (FDA)

Committee to discuss New Drug Application 21-824 for Tibotec Therapeutics' Zarnestra (tipifarnib) film-coated tablets for the treatment of elderly patients with newly diagnosed poor-risk acute myeloid leukemia

May 7-11, San Juan, Puerto Rico

19th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Includes presentations on antiviral drug and antiviral chemotherapy research

May 13, Gaithersburg, Md.

ANESTHESIOLOGY AND RESPIRATORY THERAPY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)

Committee to hear presentation on FDA's critical path initiative and a presentation from the Office of Surveillance and Biometics in the Center for Devices and Radiological Health

May 14-17, Scottsdale, Ariz.

WOUND HEALING SOCIETY 16th ANNUAL MEETING & EXHIBITION

Includes presentation from Helix BioMedix Inc. on hexapeptides for bacterial and fungal infections

May 15-20, Toronto

ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid, and its successful clinical studies

May 16-20, New York

AMERICAN SOCIETY OF HYPERTENSION ANNUAL SCIENTIFIC MEETING AND EXPOSITION

Includes presentation from Medicure Inc. on phase 2 Matched study with MC-4232 for cardiovascular and metabolic risk factors

May 17, Gaithersburg, Md.

OBSTETRICS AND GYNECOLOGY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)

Includes presentation from the Office of Surveillance and Biometrics in the Center for Devices and Radiological Health on its responsibility for the review of postmarket study design and discussion, recommendations and vote on a premarket approval application for a spectroscopy-based cervical imaging system for use as an adjunct to colposcopy to enhance the identification of biopsy sites

May 17, Gaithersburg, Md.

PERIPHERAL AND CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on Novartis Pharmaceuticals Corp.'s supplemental New Drug Application 20823, SE1-016, Exelon capsules for mild to moderate dementia associated with Parkinson's disease

May 17-18, Baltimore

INDUSTRY EXCHANGE WORKSHOP ON FOOD AND DRUG ADMINISTRATION CLINICAL TRIAL REQUIREMENTS

Public workshop in cooperation with the Society of Clinical Research Associates on FDA clinical trial statutory and regulatory requirements

May 20-25, Los Angeles

DIGESTIVE DISEASE WEEK CONFERENCE

Includes presentation from Callisto Pharmaceuticals Inc. on Guanilib for gastrointestinal inflammation; presentation from Idenix Pharmaceuticals, Inc. on Valopicitabine, an nucleoside polymerase inhibitor for hepatitis C and presentation from Cytogen Corp. on Prostascint, a diagnostic imaging agent for newly diagnosed patients with biopsy-proven prostate cancer

May 21-25, Orlando, Fla.

106th AMERICAN SOCIETY FOR MICROBIOLOGY ANNUAL GENERAL MEETING

Includes presentation from Helix BioMedix Inc. on hexapeptides for bacterial and fungal infections

May 31-June 3, Scottsdale, Ariz.

20th CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS' ANNUAL MEETING

Includes presentation from PharmaFrontiers Corp. on study of patients treated with monovalent T cell therapy

June 1-5, San Francisco

2006 ANNUAL MEETING OF THE FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES

Includes presentation from PharmaFrontiers Corp. on proprietary T-cell vaccination technology for autoimmune disease multiple sclerosis

June 2, Atlanta

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEETING (FDA)

Committee to provide advice and recommendations to the agency on FDA's regulatory issues, to discuss Bristol-Myers Squibb Co.'s New Drug Application for Sprycel (dasatinib) tablets for the treatment of adults with chronic, accelerated or blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy

June 2-6, Atlanta

2006 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING

Includes presentation from Oncolytics Biotech Inc. on Reolysin clinical trial data, Bioenvision Inc. on Evoltra for adult acute myeloid leukemia; presentation from Cytogen Corp. on Quadramet for multiple myeloma and Cell Genesys Inc. on trial of GM-CSF-gene transduced allogeneic prostate cancer cellular immunotherapy with human anti-CTLA-4 antibody for hormone-refractory prostate cancer and K562/GM-CSF vaccination for tumor burden related to chronic myelogenous leukemia

June 21-14, Amsterdam

EUROPEAN LEAGUE AGAINST RHEUMATISM 2006 ANNUAL CONGRESS

Includes presentation from Savient Pharmaceuticals Inc. on phase 2 trial results for Puricase

July 12-15, Washington

13th WORLD CONFERENCE ON TOBACCO OR HEALTH

Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure

July 23-27, Chicago

AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY ANNUAL MEETING

Includes presentation for PreMD Inc. on abstract for microwell-based format of LungAlert for lung cancer

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.